Kula Investments, LLC Revance Therapeutics, Inc. Transaction History
Kula Investments, LLC
- $405 Billion
- Q1 2023
A detailed history of Kula Investments, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Kula Investments, LLC holds 31,545 shares of RVNC stock, worth $81,070. This represents 0.25% of its overall portfolio holdings.
Number of Shares
31,545
Previous 17,961
75.63%
Holding current value
$81,070
Previous $332 Million
206.45%
% of portfolio
0.25%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
21Shares Held
10.1MCall Options Held
360KPut Options Held
0-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL423KShares$1.09 Million0.0% of portfolio
-
Rothschild & CO Asset Management Us Inc. New York, NY370KShares$949,9950.1% of portfolio
-
International Biotechnology Trust PLC London, X0289KShares$742,0251.12% of portfolio
-
Credit Suisse Ag Zurich, V8180KShares$462,9800.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...